Delivery Order 75F40123D00001-75F40124F19024

Award Date 11/2/23
Potential Completion Date 4/5/24
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ithaca, NY 14853, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $51,612 delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits. The firm fixed price contract will provide the kits to support FDA operations in Ithaca, New York over a six-month period of performance from February to August 2023. As the prime contractor, Illumina will deliver its reagent products to assist the FDA in advancing its regulatory science and public health protection missions through...
The U.S. Department of Health and Human Services Food and Drug Administration awarded Illumina, Inc. a $119,122.36 firm fixed price delivery order contract for Illumina Reagent Chemistry Kits. The place of performance is Laurel, Maryland and the period of performance is from October 26, 2023 through January 30, 2024. This delivery order was issued against an existing government-wide acquisition contract or multiple award contract vehicle held by Illumina to provide laboratory supplies and...
The Department of Health and Human Services Food and Drug Administration awarded a $31,278.75 firm fixed price delivery order to Illumina, Inc. under an unspecified contract vehicle. The order is for Illumina Reagent Chemistry Kits to be delivered to Atlanta, Georgia between April 5, 2023 and August 30, 2023. As the FDA regulates food and medical products, these kits likely support the agency's laboratory analysis and testing functions. No subcontractors or set aside designations were...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a $217,598 firm fixed price delivery order contract to Illumina, Inc. to provide Illumina Reagent Chemistry Kits. The place of performance is Laurel, Maryland and the period of performance is from June 20, 2023 through September 18, 2023. The FDA utilizes next generation sequencing technologies and associated consumables from Illumina in its regulatory review and research programs. No subcontractors or set...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $300,067.95 firm fixed price delivery order to Illumina, Inc. of Berwyn Heights, Maryland. The delivery order is for Illumina reagent chemistry kits to support the FDA's laboratory testing needs. No set-aside designation was used for this award placed against an unspecified FDA-wide acquisition contract vehicle. The delivery order has a period of performance through January 31, 2024. Illumina will provide...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded Illumina, Inc. a $28,160.45 firm fixed price delivery order contract for Illumina Reagent Chemistry Kits. The place of performance is Illumina's facility located in Irvine, California. The contract period of performance spans from February 7, 2023 through August 3, 2023. The reagent kits will support the HHS FDA's laboratory testing programs by providing the necessary consumable materials to conduct...
The Department of Health and Human Services Food and Drug Administration awarded a $31,915.95 firm fixed price delivery order to Illumina, Inc. for Illumina reagent chemistry kits. The place of performance is Atlanta, Georgia. The contract period runs from November 27, 2023 through January 30, 2024. No set aside designation or subcontractors were indicated. The FDA likely utilizes these reagent kits from Illumina, a leading provider of next-generation sequencing and array-based solutions for...
The Department of Health and Human Services Food and Drug Administration awarded a $37,819 delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits. The firm fixed price contract has a period of performance from February 21, 2023 through August 13, 2023 and will be performed in Bothell, Washington. The delivery order was issued against an unspecified multiple award contract vehicle to provide the FDA with reagents and kits needed to support the agency's laboratory testing and...
The Department of Health and Human Services Food and Drug Administration awarded a $219,167 firm fixed price delivery order to Illumina, Inc. for Illumina reagent chemistry kits. The place of performance is Laurel, Maryland and the period of performance is from February 6, 2023 through June 13, 2023. The FDA likely utilizes these reagent kits that support DNA sequencing and analysis to further its mission of protecting public health through the regulation and promotion of foods, dietary...
Illumina, Inc. has been awarded a $102,963.12 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration for Illumina reagent chemistry kits. The delivery order was issued under an indefinite delivery contract with no set-aside provisions and calls for Illumina to provide its proprietary reagent kits to support genomic sequencing and analysis at the agency through August 2024. As the sole manufacturer of the sequencing instruments in use,...
  • 75F40123D00001
    Indefinite Delivery Contract
  • 75F40123D00001-75F40124F19024
    Delivery Order

The Department of Health and Human Services Food and Drug Administration awarded a $46,724.81 firm fixed price delivery order to Illumina, Inc. for Illumina reagent chemistry kits. The place of performance is Ithaca, New York and the period of performance is from November 2, 2023 through April 5, 2024. This delivery order was issued against an existing HHS contract vehicle to provide the FDA with Illumina reagent kits, which are consumable products used in DNA sequencing and analysis. No subcontractors or set aside designations were identified. The award will support the FDA's regulatory science and public health protection programs through advanced genomic technologies.

Generated 12/22/23, 9:04 PM